Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Nov. 03, 2023 | Nov. 30, 2023 | |
Document and Entity Information | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Nov. 03, 2023 | |
Entity File Number | 001-11421 | |
Entity Registrant Name | DOLLAR GENERAL CORPORATION | |
Entity Incorporation, State or Country Code | TN | |
Entity Tax Identification Number | 61-0502302 | |
Entity Address, Address Line One | 100 MISSION RIDGE | |
Entity Address, City or Town | GOODLETTSVILLE | |
Entity Address, State or Province | TN | |
Entity Address, Postal Zip Code | 37072 | |
City Area Code | 615 | |
Local Phone Number | 855-4000 | |
Title of 12(b) Security | Common Stock, par value $0.875 per share | |
Trading Symbol | DG | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 219,497,254 | |
Current Fiscal Year End Date | --02-02 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Entity Central Index Key | 0000029534 | |
Amendment Flag | false |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Nov. 03, 2023 | Feb. 03, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 365,447 | $ 381,576 |
Merchandise inventories | 7,356,065 | 6,760,733 |
Income taxes receivable | 197,555 | 135,775 |
Prepaid expenses and other current assets | 352,011 | 302,925 |
Total current assets | 8,271,078 | 7,581,009 |
Net property and equipment | 5,848,385 | 5,236,309 |
Operating lease assets | 10,904,323 | 10,670,014 |
Goodwill | 4,338,589 | 4,338,589 |
Other intangible assets, net | 1,199,700 | 1,199,700 |
Other assets, net | 62,551 | 57,746 |
Total assets | 30,624,626 | 29,083,367 |
Current liabilities: | ||
Current portion of long-term obligations | 750,000 | |
Current portion of operating lease liabilities | 1,355,316 | 1,288,939 |
Accounts payable | 3,651,778 | 3,552,991 |
Accrued expenses and other | 1,020,759 | 1,036,919 |
Income taxes payable | 9,237 | 8,919 |
Total current liabilities | 6,787,090 | 5,887,768 |
Long-term obligations | 6,440,845 | 7,009,399 |
Long-term operating lease liabilities | 9,540,573 | 9,362,761 |
Deferred income taxes | 1,152,125 | 1,060,906 |
Other liabilities | 252,109 | 220,761 |
Commitments and contingencies | ||
Shareholders' equity: | ||
Preferred stock | ||
Common stock | 192,053 | 191,718 |
Additional paid-in capital | 3,732,376 | 3,693,871 |
Retained earnings | 2,527,201 | 1,656,140 |
Accumulated other comprehensive loss | 254 | 43 |
Total shareholders' equity | 6,451,884 | 5,541,772 |
Total liabilities and shareholders' equity | $ 30,624,626 | $ 29,083,367 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Nov. 03, 2023 | Oct. 28, 2022 | Nov. 03, 2023 | Oct. 28, 2022 | |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||
Net sales | $ 9,694,082 | $ 9,464,891 | $ 28,833,095 | $ 27,641,956 |
Cost of goods sold | 6,881,554 | 6,579,696 | 20,020,407 | 18,970,175 |
Gross profit | 2,812,528 | 2,885,195 | 8,812,688 | 8,671,781 |
Selling, general and administrative expenses | 2,379,054 | 2,149,650 | 6,946,042 | 6,276,653 |
Operating profit | 433,474 | 735,545 | 1,866,646 | 2,395,128 |
Interest expense | 82,289 | 53,681 | 249,664 | 136,455 |
Other (income) expense | 415 | 415 | ||
Income before income taxes | 351,185 | 681,449 | 1,616,982 | 2,258,258 |
Income tax expense | 74,939 | 155,282 | 357,521 | 501,404 |
Net income | $ 276,246 | $ 526,167 | $ 1,259,461 | $ 1,756,854 |
Earnings per share: | ||||
Basic (in dollars per share) | $ 1.26 | $ 2.34 | $ 5.74 | $ 7.76 |
Diluted (in dollars per share) | $ 1.26 | $ 2.33 | $ 5.73 | $ 7.72 |
Weighted average shares outstanding: | ||||
Basic (in shares) | 219,480 | 224,527 | 219,359 | 226,434 |
Diluted (in shares) | 219,799 | 225,697 | 219,953 | 227,587 |
Dividends per share | $ 0.59 | $ 0.55 | $ 1.77 | $ 1.65 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Nov. 03, 2023 | Oct. 28, 2022 | Nov. 03, 2023 | Oct. 28, 2022 | |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | ||||
Net income | $ 276,246 | $ 526,167 | $ 1,259,461 | $ 1,756,854 |
Unrealized net gain (loss) on hedged transactions and currency translation, net of related income tax expense (benefit) of $0, $87, $61, and $260, respectively | (761) | 243 | 211 | 469 |
Comprehensive income | $ 275,485 | $ 526,410 | $ 1,259,672 | $ 1,757,323 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Nov. 03, 2023 | Oct. 28, 2022 | Nov. 03, 2023 | Oct. 28, 2022 | |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | ||||
Unrealized net gain (loss) on hedged transactions, income tax expense (benefit) | $ 0 | $ 87 | $ 61 | $ 260 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total |
Balances at Jan. 28, 2022 | $ 201,265 | $ 3,587,914 | $ 2,473,999 | $ (1,192) | $ 6,261,986 |
Balances (in shares) at Jan. 28, 2022 | 230,016 | ||||
Increase (Decrease) in Shareholders' Equity | |||||
Net income | 1,756,854 | 1,756,854 | |||
Dividends paid per common share | (372,428) | (372,428) | |||
Unrealized net gain (loss) on hedged transactions and currency translation | 469 | 469 | |||
Share-based compensation expense | 57,562 | 57,562 | |||
Repurchases of common stock | $ (6,249) | (1,635,602) | (1,641,851) | ||
Repurchases of common stock (in shares) | (7,142) | ||||
Other equity and related transactions | $ 613 | 30,601 | 31,214 | ||
Other equity and related transactions (in shares) | 701 | ||||
Balances at Oct. 28, 2022 | $ 195,629 | 3,676,077 | 2,222,823 | (723) | 6,093,806 |
Balances (in shares) at Oct. 28, 2022 | 223,575 | ||||
Balances at Jul. 29, 2022 | $ 197,372 | 3,627,987 | 2,364,098 | (966) | 6,188,491 |
Balances (in shares) at Jul. 29, 2022 | 225,567 | ||||
Increase (Decrease) in Shareholders' Equity | |||||
Net income | 526,167 | 526,167 | |||
Dividends paid per common share | (122,960) | (122,960) | |||
Unrealized net gain (loss) on hedged transactions and currency translation | 243 | 243 | |||
Share-based compensation expense | 15,469 | 15,469 | |||
Repurchases of common stock | $ (1,973) | (544,482) | (546,455) | ||
Repurchases of common stock (in shares) | (2,256) | ||||
Other equity and related transactions | $ 230 | 32,621 | 32,851 | ||
Other equity and related transactions (in shares) | 264 | ||||
Balances at Oct. 28, 2022 | $ 195,629 | 3,676,077 | 2,222,823 | (723) | 6,093,806 |
Balances (in shares) at Oct. 28, 2022 | 223,575 | ||||
Balances at Feb. 03, 2023 | $ 191,718 | 3,693,871 | 1,656,140 | 43 | 5,541,772 |
Balances (in shares) at Feb. 03, 2023 | 219,105 | ||||
Increase (Decrease) in Shareholders' Equity | |||||
Net income | 1,259,461 | 1,259,461 | |||
Dividends paid per common share | (388,400) | (388,400) | |||
Unrealized net gain (loss) on hedged transactions and currency translation | 211 | 211 | |||
Share-based compensation expense | 40,704 | 40,704 | |||
Other equity and related transactions | $ 335 | (2,199) | (1,864) | ||
Other equity and related transactions (in shares) | 385 | ||||
Balances at Nov. 03, 2023 | $ 192,053 | 3,732,376 | 2,527,201 | 254 | 6,451,884 |
Balances (in shares) at Nov. 03, 2023 | 219,490 | ||||
Balances at Aug. 04, 2023 | $ 192,039 | 3,724,200 | 2,380,451 | 1,015 | 6,297,705 |
Balances (in shares) at Aug. 04, 2023 | 219,470 | ||||
Increase (Decrease) in Shareholders' Equity | |||||
Net income | 276,246 | 276,246 | |||
Dividends paid per common share | (129,496) | (129,496) | |||
Unrealized net gain (loss) on hedged transactions and currency translation | (761) | (761) | |||
Share-based compensation expense | 6,811 | 6,811 | |||
Other equity and related transactions | $ 14 | 1,365 | 1,379 | ||
Other equity and related transactions (in shares) | 20 | ||||
Balances at Nov. 03, 2023 | $ 192,053 | $ 3,732,376 | $ 2,527,201 | $ 254 | $ 6,451,884 |
Balances (in shares) at Nov. 03, 2023 | 219,490 |
CONDENSED CONSOLIDATED STATEM_5
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - $ / shares | 3 Months Ended | 9 Months Ended | ||||
Nov. 03, 2023 | Aug. 04, 2023 | May 05, 2023 | Oct. 28, 2022 | Nov. 03, 2023 | Oct. 28, 2022 | |
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY | ||||||
Dividends per share | $ 0.59 | $ 0.59 | $ 0.59 | $ 0.55 | $ 1.77 | $ 1.65 |
CONDENSED CONSOLIDATED STATEM_6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 9 Months Ended | |
Nov. 03, 2023 | Oct. 28, 2022 | |
Cash flows from operating activities: | ||
Net income | $ 1,259,461 | $ 1,756,854 |
Adjustments to reconcile net income to net cash from operating activities: | ||
Depreciation and amortization | 625,817 | 532,514 |
Deferred income taxes | 91,158 | 166,965 |
Noncash share-based compensation | 40,704 | 57,562 |
Other noncash (gains) and losses | 79,001 | 365,500 |
Change in operating assets and liabilities: | ||
Merchandise inventories | (661,611) | (1,885,434) |
Prepaid expenses and other current assets | (50,846) | (81,836) |
Accounts payable | 108,757 | 377,478 |
Accrued expenses and other liabilities | 3,802 | 54,134 |
Income taxes | (61,462) | (90,737) |
Other | 7,238 | (4,813) |
Net cash provided by (used in) operating activities | 1,442,019 | 1,248,187 |
Cash flows from investing activities: | ||
Purchases of property and equipment | (1,240,507) | (1,078,208) |
Proceeds from sales of property and equipment | 4,963 | 2,388 |
Net cash provided by (used in) investing activities | (1,235,544) | (1,075,820) |
Cash flows from financing activities: | ||
Issuance of long-term obligations | 1,498,260 | 2,296,053 |
Repayments of long-term obligations | (14,362) | (907,731) |
Net increase (decrease) in commercial paper outstanding | (1,303,800) | 456,800 |
Borrowings under revolving credit facilities | 500,000 | |
Repayments of borrowings under revolving credit facilities | (500,000) | |
Costs associated with issuance of debt | (12,438) | (16,521) |
Repurchases of common stock | (1,641,851) | |
Payments of cash dividends | (388,381) | (372,423) |
Other equity and related transactions | (1,883) | 31,208 |
Net cash provided by (used in) financing activities | (222,604) | (154,465) |
Net increase (decrease) in cash and cash equivalents | (16,129) | 17,902 |
Cash and cash equivalents, beginning of period | 381,576 | 344,829 |
Cash and cash equivalents, end of period | 365,447 | 362,731 |
Supplemental noncash investing and financing activities: | ||
Right of use assets obtained in exchange for new operating lease liabilities | 1,248,662 | 1,314,045 |
Purchases of property and equipment awaiting processing for payment, included in Accounts payable | $ 140,724 | $ 152,579 |
Basis of presentation
Basis of presentation | 9 Months Ended |
Nov. 03, 2023 | |
Basis of presentation | |
Basis of presentation | 1. Basis of presentation The accompanying unaudited condensed consolidated financial statements of Dollar General Corporation (which individually or together with its subsidiaries, as the context requires, is referred to as the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and are presented in accordance with the requirements of Form 10-Q and Rule 10-01 of Regulation S-X. Such financial statements consequently do not include all of the disclosures normally required by U.S. GAAP for annual financial statements or those normally made in the Company’s Annual Report on Form 10-K, including the condensed consolidated balance sheet as of February 3, 2023 which was derived from the audited consolidated financial statements at that date. Accordingly, readers of this Quarterly Report on Form 10-Q should refer to the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2023 for additional information. The Company’s fiscal year ends on the Friday closest to January 31. Unless the context requires otherwise, references to years contained herein pertain to the Company’s fiscal year. The Company’s 2023 fiscal year is a 52-week accounting period ending on February 2, 2024, and the 2022 fiscal year was a 53-week accounting period that ended on February 3, 2023. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the Company’s customary accounting practices. In management’s opinion, all adjustments (which are of a normal recurring nature) necessary for a fair presentation of the consolidated financial position as of November 3, 2023 and results of operations for the 13-week and 39-week accounting periods ended November 3, 2023 and October 28, 2022 have been made. The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Because the Company’s business is moderately seasonal, the results for interim periods are not necessarily indicative of the results to be expected for the entire year. The Company uses the last-in, first-out (“LIFO”) method of valuing inventory. An actual valuation of inventory under the LIFO method is made at the end of each year based on the inventory levels and costs at that time. Accordingly, interim LIFO calculations are based on management’s estimates of expected year-end inventory levels, sales for the year and the expected rate of inflation or deflation for the year. The interim LIFO calculations are subject to adjustment in the final year-end LIFO inventory valuation. The Company recorded a LIFO provision of $11.3 million and $147.8 million in the respective 13-week periods, and $59.7 million and $353.6 million in the respective 39-week periods, ended November 3, 2023 and October 28, 2022. In addition, ongoing estimates of inventory shrinkage and initial markups and markdowns are included in the interim cost of goods sold calculation. We utilize supply chain finance programs whereby qualifying suppliers may elect at their sole discretion to sell our payment obligations to designated third party financial institutions. While the terms of these agreements are between the supplier and the financial institution, the supply chain finance financial institutions allow the participating suppliers to utilize our creditworthiness in establishing credit spreads and associated costs. The Company’s obligations to its suppliers in accounts payable, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under these arrangements. As of November 3, 2023 and February 3, 2023, the obligations outstanding at the end of the reporting period were $299.9 million and $343.6 million, respectively. In November 2023, the FASB issued an update to the required disclosures for segment reporting. The update is intended to improve reportable segment disclosures, primarily through enhanced disclosures about significant segment expenses. The update is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company does not expect the adoption of this update to have a material impact on its consolidated results of operations, financial position, or cash flows. In September 2022, the FASB issued new required disclosures for supplier finance programs. These disclosures are intended to enhance the transparency about the use of supplier finance programs for investors. The amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with the exception of the disclosure of rollforward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted the required disclosures for this accounting standard update in fiscal 2023, except for the disclosure of rollforward activity, which will be adopted for fiscal year 2024. In March 2020 and January 2021, the Financial Accounting Standards Board (“FASB”) issued accounting standards updates pertaining to reference rate reform. This collective guidance is in response to accounting concerns regarding contract modifications and hedge accounting because of impending rate reform associated with structural risks of interbank offered rates (IBORs), and, particularly, the risk of cessation of LIBOR, related to regulators in several jurisdictions around the world having undertaken reference rate reform initiatives to identify alternative reference rates. The guidance provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The adoption of this guidance is effective for all entities as of March 12, 2020 through December 31, 2024. The Company completed its transition from LIBOR to Term SOFR in its credit agreements governing the Facilities in fiscal year 2022 with no material impact to the financial statements. |
Earnings per share
Earnings per share | 9 Months Ended |
Nov. 03, 2023 | |
Earnings per share: | |
Earnings per share | 2. Earnings per share Earnings per share is computed as follows (in thousands, except per share data): 13 Weeks Ended November 3, 2023 13 Weeks Ended October 28, 2022 Weighted Weighted Net Average Per Share Net Average Per Share Income Shares Amount Income Shares Amount Basic earnings per share $ 276,246 219,480 $ 1.26 $ 526,167 224,527 $ 2.34 Effect of dilutive share-based awards 319 1,170 Diluted earnings per share $ 276,246 219,799 $ 1.26 $ 526,167 225,697 $ 2.33 39 Weeks Ended November 3, 2023 39 Weeks Ended October 28, 2022 Weighted Weighted Net Average Per Share Net Average Per Share Income Shares Amount Income Shares Amount Basic earnings per share $ 1,259,461 219,359 $ 5.74 $ 1,756,854 226,434 $ 7.76 Effect of dilutive share-based awards 594 1,153 Diluted earnings per share $ 1,259,461 219,953 $ 5.73 $ 1,756,854 227,587 $ 7.72 Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is determined based on the dilutive effect of share-based awards using the treasury stock method. Share-based awards that were outstanding at the end of the respective periods but were not included in the computation of diluted earnings per share because the effect of exercising such awards would be antidilutive, were approximately 0.1 million in each of the respective 13-week periods and 39-week periods ended November 3, 2023 and October 28, 2022. |
Income taxes
Income taxes | 9 Months Ended |
Nov. 03, 2023 | |
Income taxes | |
Income taxes | 3. Income taxes Under the accounting standards for income taxes, the asset and liability method is used for computing the future income tax consequences of events that have been recognized in the Company’s consolidated financial statements or income tax returns. Income tax reserves are determined using the methodology established by accounting standards for income taxes which require companies to assess each income tax position taken using the following two-step approach. A determination is first made as to whether it is more likely than not that the position will be sustained, based upon the technical merits, upon examination by the taxing authorities. If the tax position is expected to meet the more likely than not criteria, the benefit recorded for the tax position equals the largest amount that is greater than 50% likely to be realized upon ultimate settlement of the respective tax position. The Company’s 2019 and earlier tax years are not open for further examination by the Internal Revenue Service (“IRS”). The IRS, at its discretion, may choose to examine the Company’s 2020 through 2022 fiscal year income tax filings. The Company has various state income tax examinations that are currently in progress. Generally, with few exceptions, the Company’s 2020 and later tax years remain open for examination by the various state taxing authorities. As of November 3, 2023, the total reserves for uncertain tax benefits, interest expense related to income taxes and potential income tax penalties were $14.8 million, $1.0 million and $0.0 million, respectively, for a total of $15.8 million. The uncertain tax liability is reflected in noncurrent other liabilities in the condensed consolidated balance sheet. The Company’s reserve for uncertain tax positions is expected to be reduced by $1.9 million in the coming twelve months as a result of expiring statutes of limitations or settlements. As of November 3, 2023, approximately $12.6 million of the reserve for uncertain tax positions would impact the Company’s effective income tax rate if the Company were to recognize the tax benefit for these positions. The effective income tax rates for the 13-week and 39-week periods ended November 3, 2023 were 21.3% and 22.1% respectively, compared to rates of 22.8% and 22.2% for the 13-week and 39-week periods ended October 28, 2022. The effective income tax rate was lower for the 13-week period in 2023 than the comparable 13-week period in 2022 primarily due to increased benefits from federal employment tax credits and an increased benefit to the effective tax rate from rate-impacting items caused by lower earnings before taxes in the 13-week period in 2023 offset by a higher state effective tax rate. The effective income tax rate was lower for the 39-week period in 2023 than the comparable 39-week period in 2022 primarily due to a reduced benefit from stock-based compensation and a higher state effective income tax rate offset by an increased benefit to the effective tax rate from rate-impacting items caused by lower earnings before taxes in the 39-week period in 2023. |
Leases
Leases | 9 Months Ended |
Nov. 03, 2023 | |
Leases | |
Leases | 4. Leases As of November 3, 2023, the Company’s primary leasing activities were real estate leases for most of its retail store locations and certain of its distribution facilities. Substantially all of the Company’s leases are classified as operating leases and the associated assets and liabilities are presented as separate captions in the condensed consolidated balance sheets. Finance lease assets are included in net property and equipment, and finance lease liabilities are included in long-term obligations, in the condensed consolidated balance sheets. At November 3, 2023, the weighted-average remaining lease term for the Company’s operating leases was 9.3 years, and the weighted average discount rate for such leases was 4.1%. Operating lease costs are reflected as selling, general and administrative costs in the condensed consolidated statements of income. For the 39-week periods ended November 3, 2023 and October 28, 2022, such costs were $1.30 billion and $1.19 billion, respectively. Cash paid for amounts included in the measurement of operating lease liabilities of $1.30 billion and $1.20 billion, respectively, were reflected in cash flows from operating activities in the condensed consolidated statements of cash flows for the 39-week periods ended November 3, 2023 and October 28, 2022. |
Current and long-term obligatio
Current and long-term obligations | 9 Months Ended |
Nov. 03, 2023 | |
Current and long-term obligations | |
Current and long-term obligations | 5. Current and long-term obligations Current and long-term obligations consist of the following: November 3, February 3, (In thousands) 2023 2023 Revolving Facility $ — $ — 364-Day Revolving Facility — — 4.250% Senior Notes due September 20, 2024 (net of discount of $315 and $563) 749,685 749,437 4.150% Senior Notes due November 1, 2025 (net of discount of $184 and $249) 499,816 499,751 3.875% Senior Notes due April 15, 2027 (net of discount of $172 and $207) 599,828 599,793 4.625% Senior Notes due November 1, 2027 (net of discount of $424 and $495) 549,576 549,505 4.125% Senior Notes due May 1, 2028 (net of discount of $250 and $287) 499,750 499,713 5.200% Senior Notes due July 5, 2028 (net of discount of $130 and $0) 499,870 — 3.500% Senior Notes due April 3, 2030 (net of discount of $457 and $504) 940,823 952,440 5.000% Senior Notes due November 1, 2032 (net of discount of $2,204 and $2,346) 697,796 697,654 5.450% Senior Notes due July 5, 2033 (net of discount of $1,551 and $0) 998,449 — 4.125% Senior Notes due April 3, 2050 (net of discount of $4,695 and $4,766) 495,305 495,234 5.500% Senior Notes due November 1, 2052 (net of discount of $289 and $292) 299,711 299,708 Unsecured commercial paper notes 198,100 1,501,900 Other 205,619 200,695 Debt issuance costs, net (43,483) (36,431) $ 7,190,845 $ 7,009,399 Less: current portion (750,000) — Long-term obligations $ 6,440,845 $ 7,009,399 The Company has a $2.0 billion senior unsecured revolving credit facility (the “Revolving Facility”) scheduled to mature on December 2, 2026, up to $100.0 million of which is available for letters of credit. Borrowings under the Revolving Facility bear interest at a rate equal to an applicable interest rate margin plus, at the Company’s option, either (a) Adjusted Term SOFR (which is Term SOFR, as published by CME Group Benchmark Administration Limited, plus a credit spread adjustment of 0.10%) or (b) a base rate (which is usually equal to the prime rate). The applicable interest rate margin for borrowings as of November 3, 2023 was 1.015% for Adjusted Term SOFR borrowings and 0.015% for base-rate borrowings. The Company is also required to pay a facility fee, payable on any used and unused commitment amounts of the Revolving Facility, and customary fees on letters of credit issued under the Revolving Facility. As of November 3, 2023, the facility fee rate was 0.11%. The applicable interest rate margins for borrowings, the facility fees and the letter of credit fees under the Revolving Facility are subject to adjustment from time to time based on the Company’s long-term senior unsecured debt ratings. The Company has a 364-day $750 million unsecured revolving credit facility (the “364-Day Revolving Facility”) which will expire on January 30, 2024. Borrowings under the 364-Day Revolving Facility bear interest at a rate equal to an applicable interest rate margin plus, at the Company’s option, either (a) Adjusted Term SOFR (which is Term SOFR, as published by CME Group Benchmark Administration Limited, plus a credit spread adjustment of 0.10%) or (b) a base rate (which is usually equal to the prime rate). The Company is also required to pay a facility fee to the lenders under the 364-Day Revolving Facility for any used and unused commitments. As of November 3, 2023, the applicable interest rate margin for Adjusted Term SOFR loans was 1.035% and the facility fee rate was 0.09%. The applicable interest rate margins for borrowings and the facility fees under the 364-Day Revolving Facility are subject to adjustment from time to time based on the Company’s long-term senior unsecured debt ratings. The credit agreements governing the Revolving Facility and the 364-Day Revolving Facility (together, the “Facilities”) contain a number of customary affirmative and negative covenants that, among other things, restrict, subject to certain exceptions, the Company’s ability to: incur additional liens; sell all or substantially all of the Company’s assets; consummate certain fundamental changes or change in the Company’s lines of business; and incur additional subsidiary indebtedness. The credit agreements governing the Facilities also contain financial covenants which require the maintenance of a minimum fixed charge coverage ratio and a maximum leverage ratio. As of November 3, 2023, the Company was in compliance with all such covenants. The credit agreements governing each of the Facilities also contain customary events of default. As of November 3, 2023, the Company had no outstanding borrowings, no outstanding letters of credit, and approximately $2.0 billion of borrowing availability under the Revolving Facility that, due to the Company’s intention to maintain borrowing availability related to the commercial paper program described below, could contribute incremental liquidity of $1.6 billion. As of November 3, 2023, under the 364-Day Revolving Facility, the Company had no outstanding borrowings and borrowing availability of $750.0 million. As of November 3, 2023, the Company had combined availability under the Facilities of $2.4 billion. As of November 3, 2023, the Company had a commercial paper program under which the Company may issue unsecured commercial paper notes (the “CP Notes”) from time to time in an aggregate amount not to exceed $2.0 billion outstanding at any time. The CP Notes may have maturities of up to 364 days from the date of issue and rank equal in right of payment with all of the Company’s other unsecured and unsubordinated indebtedness. The Company intends to maintain available commitments under the Revolving Facility in an amount at least equal to the amount of CP Notes outstanding at any time. As of November 3, 2023, the Company’s condensed consolidated balance sheet reflected outstanding unsecured CP Notes of $198.1 million, which had a weighted average borrowing rate of 5.4%. CP Notes totaling $197.7 million and $230.8 million at November 3, 2023 and February 3, 2023, respectively, were held by a wholly-owned subsidiary of the Company and are therefore not reflected in the condensed consolidated balance sheets. On June 7, 2023, the Company issued $500.0 million aggregate principal amount of 5.20% senior notes due 2028 (the “July 2028 Senior Notes”), net of discount of $0.1 million, and $1.0 billion aggregate principal amount of 5.45% senior notes due 2033 (the “2033 Senior Notes”), net of discount of $1.6 million. The July 2028 Senior Notes are scheduled to mature on July 5, 2028, and the 2033 Senior Notes are scheduled to mature on July 5, 2033. Interest on the July 2028 Senior Notes and the 2033 Senior Notes is payable in cash on January 5 and July 5 of each year, commencing on January 5, 2024. The Company incurred $12.4 million of debt issuance costs associated with the issuance of the July 2028 Senior Notes and the 2033 Senior Notes. |
Assets and liabilities measured
Assets and liabilities measured at fair value | 9 Months Ended |
Nov. 03, 2023 | |
Assets and liabilities measured at fair value | |
Assets and liabilities measured at fair value | 6. Assets and liabilities measured at fair value Fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, fair value accounting standards establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). The Company does not have any fair value measurements categorized within Level 3 as of November 3, 2023. The following table presents the Company’s liabilities required to be measured at fair value as of November 3, 2023, aggregated by the level in the fair value hierarchy within which those measurements are classified. Quoted Prices in Active Markets Significant for Identical Other Significant Total Fair Assets and Observable Unobservable Value at Liabilities Inputs Inputs November 3, (In thousands) (Level 1) (Level 2) (Level 3) 2023 Liabilities: Current and long-term obligations (a) $ 6,318,958 $ 403,719 $ — $ 6,722,677 Deferred compensation (b) 46,115 — — 46,115 (a) Included in the condensed consolidated balance sheet at book value as current portion of long-term obligations of $750,000 and long-term obligations of $6,440,845 . (b) Reflected at fair value in the condensed consolidated balance sheet as accrued expenses and other current liabilities of $10,164 and noncurrent other liabilities of $35,951 . |
Commitments and contingencies
Commitments and contingencies | 9 Months Ended |
Nov. 03, 2023 | |
Commitments and contingencies | |
Commitments and contingencies | 7. Commitments and contingencies Legal proceedings From time to time, the Company is a party to various legal matters in the ordinary course of its business, including actions by employees, consumers, suppliers, government agencies, or others. The Company has recorded accruals with respect to these matters, where appropriate, which are reflected in the Company’s condensed consolidated financial statements. For some matters, a liability is not probable or the amount cannot be reasonably estimated and therefore an accrual has not been made. On January 20, 2023, a lawsuit entitled Brent Conforti, et al. v. Jeffrey C. Owen, et al. was filed in the United States District Court for the Middle District of Tennessee (Case No. 3:23-CV-00059) (“Conforti”) in which the plaintiff shareholder, purportedly on behalf and for the benefit of the Company, alleges that each of the Company’s directors violated their fiduciary duties by failing to implement and maintain a system of controls regarding the Company’s workplace safety practices. The plaintiff also alleges corporate waste and, as to the Company’s then former CEO, Mr. Vasos, unjust enrichment. On February 13, 2023, the plaintiff amended the complaint to add breach of fiduciary duty allegations against certain then officers of the Company, including Messrs. Owen, Vasos, Garratt, Sunderland and Wenkoff and Mss. R. Taylor and Elliott, and to expand the unjust enrichment claim to include all individual director and officer defendants (the “Individual Defendants”). The plaintiff seeks both non-monetary and monetary relief for the benefit of the Company. On October 12, 2023, the court granted in its entirety the motion to dismiss filed by the Company and the Individual Defendants. On November 27, 2023, and November 30, 2023, respectively, the following putative shareholder class action lawsuits were filed in the United States District Court for the Middle District of Tennessee in which the plaintiffs allege that during the putative class periods noted below, the Company and certain of its current and former officers violated the federal securities laws by misrepresenting the impact of alleged store labor, inventory, pricing and other practices on the Company’s financial results and prospects: Washtenaw County Employees’ Retirement System v. Dollar General Corporation, et al. (Case No. 3:23-cv-01250) (putative class period of May 28, 2020 to August 30, 2023); Robert J. Edmonds v. Dollar General Corporation, et al. (Case No. 3:23-cv-01259) (putative class period of February 23, 2023 to August 31, 2023) (collectively, the “Shareholder Securities Litigation”). The plaintiffs seek compensatory damages, equitable/injunctive relief, pre- and post-judgment interest and attorneys’ fees and costs. The deadline to seek appointment by the Court to serve as the lead plaintiff in the Shareholder Securities Litigation is January 26, 2024. At this time, it is not possible to estimate the value of the claims asserted in the Shareholder Securities Litigation or the potential range of loss in this matter, and no assurances can be given that the Company will be successful in its defense on the merits or otherwise. However, if the Company is not successful in its defense efforts, the resolution of the Shareholder Securities Litigation could have a material adverse effect on the Company’s consolidated financial statements as a whole. Based on information currently available, the Company believes that its pending legal matters, both individually and in the aggregate, will be resolved without a material adverse effect on the Company’s consolidated financial statements as a whole. However, litigation and other legal matters involve an element of uncertainty. Adverse decisions and settlements, including any required changes to the Company’s business, or other developments in such matters could affect the consolidated operating results in future periods or result in liability or other amounts material to the Company’s annual consolidated financial statements. |
Segment reporting
Segment reporting | 9 Months Ended |
Nov. 03, 2023 | |
Segment reporting | |
Segment reporting | 8. Segment reporting The Company manages its business on the basis of one reportable operating segment. As of November 3, 2023, the Company’s retail store operations were primarily located within the United States, with two retail stores in Mexico. Certain product sourcing and other operations are located outside the United States, which collectively are not material with regard to assets, results of operations or otherwise to the consolidated financial statements. The following net sales data is presented in accordance with accounting standards related to disclosures about segments of an enterprise. 13 Weeks Ended 39 Weeks Ended November 3, October 28, November 3, October 28, (in thousands) 2023 2022 2023 2022 Classes of similar products: Consumables $ 7,940,527 $ 7,664,806 $ 23,445,031 $ 22,101,146 Seasonal 940,632 942,831 2,979,474 2,991,113 Home products 534,471 574,425 1,582,305 1,674,013 Apparel 278,452 282,829 826,285 875,684 Net sales $ 9,694,082 $ 9,464,891 $ 28,833,095 $ 27,641,956 |
Common stock transactions
Common stock transactions | 9 Months Ended |
Nov. 03, 2023 | |
Common stock transactions | |
Common stock transactions | 9. Common stock transactions On August 29, 2012, the Company’s Board of Directors (the “Board”) authorized a common stock repurchase program, which the Board has since increased on several occasions. On August 24, 2022, the Board authorized a $2.0 billion increase to the existing common stock repurchase program, bringing the cumulative total to $16.0 billion authorized under the program since its inception in 2012. The repurchase authorization has no expiration date and allows repurchases from time to time in open market transactions, including pursuant to trading plans adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, or in privately negotiated transactions. The timing, manner and number of shares repurchased will depend on a variety of factors, including price, market conditions, compliance with the covenants and restrictions under the Company’s debt agreements, cash requirements, excess debt capacity, results of operations, financial condition and other factors. Repurchases under the program may be funded from available cash or borrowings, including under the Facilities and issuance of CP Notes discussed in further detail in Note 5, or otherwise. Pursuant to its common stock repurchase program, during the 39-week periods ended November 3, 2023 and October 28, 2022, respectively, the Company repurchased in the open market no shares of its common stock and 7.1 million shares of its common stock at a total cost of $1.6 billion. The Company paid a cash dividend of $0.59 per share during each of the first three quarters of 2023. In December 2023, the Board declared a quarterly cash dividend of $0.59 per share, which is payable on or before January 23, 2023, to shareholders of record on January 9, 2023. The amount and declaration of future cash dividends is subject to the sole discretion of the Board and will depend upon, among other things, the Company’s results of operations, cash requirements, financial condition, contractual restrictions, excess debt capacity, and other factors that the Board may deem relevant in its sole discretion. |
Earnings per share (Tables)
Earnings per share (Tables) | 9 Months Ended |
Nov. 03, 2023 | |
Earnings per share: | |
Schedule of computation of earnings per share | Earnings per share is computed as follows (in thousands, except per share data): 13 Weeks Ended November 3, 2023 13 Weeks Ended October 28, 2022 Weighted Weighted Net Average Per Share Net Average Per Share Income Shares Amount Income Shares Amount Basic earnings per share $ 276,246 219,480 $ 1.26 $ 526,167 224,527 $ 2.34 Effect of dilutive share-based awards 319 1,170 Diluted earnings per share $ 276,246 219,799 $ 1.26 $ 526,167 225,697 $ 2.33 39 Weeks Ended November 3, 2023 39 Weeks Ended October 28, 2022 Weighted Weighted Net Average Per Share Net Average Per Share Income Shares Amount Income Shares Amount Basic earnings per share $ 1,259,461 219,359 $ 5.74 $ 1,756,854 226,434 $ 7.76 Effect of dilutive share-based awards 594 1,153 Diluted earnings per share $ 1,259,461 219,953 $ 5.73 $ 1,756,854 227,587 $ 7.72 |
Current and long-term obligat_2
Current and long-term obligations (Tables) | 9 Months Ended |
Nov. 03, 2023 | |
Current and long-term obligations | |
Schedule of current and long-term debt obligations | November 3, February 3, (In thousands) 2023 2023 Revolving Facility $ — $ — 364-Day Revolving Facility — — 4.250% Senior Notes due September 20, 2024 (net of discount of $315 and $563) 749,685 749,437 4.150% Senior Notes due November 1, 2025 (net of discount of $184 and $249) 499,816 499,751 3.875% Senior Notes due April 15, 2027 (net of discount of $172 and $207) 599,828 599,793 4.625% Senior Notes due November 1, 2027 (net of discount of $424 and $495) 549,576 549,505 4.125% Senior Notes due May 1, 2028 (net of discount of $250 and $287) 499,750 499,713 5.200% Senior Notes due July 5, 2028 (net of discount of $130 and $0) 499,870 — 3.500% Senior Notes due April 3, 2030 (net of discount of $457 and $504) 940,823 952,440 5.000% Senior Notes due November 1, 2032 (net of discount of $2,204 and $2,346) 697,796 697,654 5.450% Senior Notes due July 5, 2033 (net of discount of $1,551 and $0) 998,449 — 4.125% Senior Notes due April 3, 2050 (net of discount of $4,695 and $4,766) 495,305 495,234 5.500% Senior Notes due November 1, 2052 (net of discount of $289 and $292) 299,711 299,708 Unsecured commercial paper notes 198,100 1,501,900 Other 205,619 200,695 Debt issuance costs, net (43,483) (36,431) $ 7,190,845 $ 7,009,399 Less: current portion (750,000) — Long-term obligations $ 6,440,845 $ 7,009,399 |
Assets and liabilities measur_2
Assets and liabilities measured at fair value (Tables) | 9 Months Ended |
Nov. 03, 2023 | |
Assets and liabilities measured at fair value | |
Schedule of assets and liabilities measured at fair value | Quoted Prices in Active Markets Significant for Identical Other Significant Total Fair Assets and Observable Unobservable Value at Liabilities Inputs Inputs November 3, (In thousands) (Level 1) (Level 2) (Level 3) 2023 Liabilities: Current and long-term obligations (a) $ 6,318,958 $ 403,719 $ — $ 6,722,677 Deferred compensation (b) 46,115 — — 46,115 (a) Included in the condensed consolidated balance sheet at book value as current portion of long-term obligations of $750,000 and long-term obligations of $6,440,845 . (b) Reflected at fair value in the condensed consolidated balance sheet as accrued expenses and other current liabilities of $10,164 and noncurrent other liabilities of $35,951 . |
Segment reporting (Tables)
Segment reporting (Tables) | 9 Months Ended |
Nov. 03, 2023 | |
Segment reporting | |
Schedule of net sales grouped by classes of similar products | 13 Weeks Ended 39 Weeks Ended November 3, October 28, November 3, October 28, (in thousands) 2023 2022 2023 2022 Classes of similar products: Consumables $ 7,940,527 $ 7,664,806 $ 23,445,031 $ 22,101,146 Seasonal 940,632 942,831 2,979,474 2,991,113 Home products 534,471 574,425 1,582,305 1,674,013 Apparel 278,452 282,829 826,285 875,684 Net sales $ 9,694,082 $ 9,464,891 $ 28,833,095 $ 27,641,956 |
Basis of presentation (Details)
Basis of presentation (Details) $ in Millions | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||
Nov. 03, 2023 USD ($) | Oct. 28, 2022 USD ($) | Nov. 03, 2023 USD ($) | Oct. 28, 2022 USD ($) | Feb. 02, 2024 period | Feb. 03, 2023 USD ($) period | |
Fiscal year, number of weeks | period | 52 | 53 | ||||
Merchandise inventories | ||||||
LIFO provision | $ 11.3 | $ 147.8 | $ 59.7 | $ 353.6 | ||
Supply Chain Finance Program | ||||||
Contractual Obligation | $ 299.9 | $ 299.9 | $ 343.6 |
Earnings per share (Details)
Earnings per share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Nov. 03, 2023 | Oct. 28, 2022 | Nov. 03, 2023 | Oct. 28, 2022 | |
Net Income | ||||
Basic Earnings | $ 276,246 | $ 526,167 | $ 1,259,461 | $ 1,756,854 |
Diluted Earnings | $ 276,246 | $ 526,167 | $ 1,259,461 | $ 1,756,854 |
Shares | ||||
Shares outstanding, basic | 219,480 | 224,527 | 219,359 | 226,434 |
Effect of dilutive share-based awards | 319 | 1,170 | 594 | 1,153 |
Shares outstanding, diluted | 219,799 | 225,697 | 219,953 | 227,587 |
Per Share Amount | ||||
Basic earnings per share (in dollars per share) | $ 1.26 | $ 2.34 | $ 5.74 | $ 7.76 |
Diluted earnings per share (in dollars per share) | $ 1.26 | $ 2.33 | $ 5.73 | $ 7.72 |
Share-based awards outstanding excluded from computation of diluted earnings per share | 100 | 100 | 100 | 100 |
Income taxes (Details)
Income taxes (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Nov. 03, 2023 | Oct. 28, 2022 | Nov. 03, 2023 | Oct. 28, 2022 | |
Income taxes | ||||
Reserves for uncertain tax benefits | $ 14.8 | $ 14.8 | ||
Interest accrued related to uncertain tax benefits | 1 | 1 | ||
Potential penalties accrued related to uncertain tax benefits | 0 | 0 | ||
Reserves for uncertain tax benefits included in noncurrent Other liabilities | 15.8 | 15.8 | ||
Reserve for uncertain tax positions for which a reduction is reasonably possible in the next twelve months | 1.9 | 1.9 | ||
Reserve for uncertain tax positions that would impact effective tax rate if recognized | $ 12.6 | $ 12.6 | ||
Effective income tax rates (as a percent) | 21.30% | 22.80% | 22.10% | 22.20% |
Leases (Details)
Leases (Details) - USD ($) $ in Millions | 9 Months Ended | |
Nov. 03, 2023 | Oct. 28, 2022 | |
Leases | ||
Weighted-average remaining lease term | 9 years 3 months 18 days | |
Weighed average discount rate | 4.10% | |
Operating lease cost | $ 1,300 | $ 1,190 |
Cash paid for operating leases | $ 1,300 | $ 1,200 |
Current and long-term obligat_3
Current and long-term obligations (Details) - USD ($) $ in Thousands | 9 Months Ended | ||
Nov. 03, 2023 | Jun. 07, 2023 | Feb. 03, 2023 | |
Current and long-term obligations | |||
Other | $ 205,619 | ||
Debt issuance costs, net | (43,483) | $ (36,431) | |
Current and long-term obligations | 7,190,845 | 7,009,399 | |
Less: current portion | (750,000) | ||
Long-term obligations | 6,440,845 | 7,009,399 | |
Other | 200,695 | ||
Credit Facilities | |||
Current and long-term obligations | |||
Borrowing availability under credit facility | 2,400,000 | ||
Senior unsecured credit facility, Revolving Facility | |||
Current and long-term obligations | |||
Long-term obligations | 0 | ||
Maximum financing under credit agreements | $ 2,000,000 | ||
Spread on variable rate (as a percent) | 1.015% | ||
Facility fee rate | 0.11% | ||
Borrowing availability under credit facility | $ 2,000,000 | ||
Borrowing availability except for amount reserved for commercial paper program | $ 1,600,000 | ||
Senior unsecured credit facility, Revolving Facility | Base-rate loans | |||
Current and long-term obligations | |||
Spread on variable rate (as a percent) | 0.015% | ||
Senior unsecured credit facility, Revolving Facility | SOFR | |||
Current and long-term obligations | |||
Spread on variable rate (as a percent) | 0.10% | ||
Senior unsecured credit facility, Revolving Facility | Letters of credit | |||
Current and long-term obligations | |||
Maximum financing under credit agreements | $ 100,000 | ||
Letters of credit outstanding | 0 | ||
Unsecured 364 Day Credit Facility | |||
Current and long-term obligations | |||
364-Day Revolving Facility | 0 | ||
Maximum financing under credit agreements | $ 750,000 | ||
Facility fee rate | 0.09% | ||
Borrowing availability under credit facility | $ 750,000 | ||
Unsecured 364 Day Credit Facility | SOFR | |||
Current and long-term obligations | |||
Spread on variable rate (as a percent) | 0.10% | ||
Adjusted interest rate margin | 1.035% | ||
4.250% Senior Notes due September 20, 2024 | |||
Current and long-term obligations | |||
Long-term obligations | $ 749,685 | 749,437 | |
Discount on debt issuance | $ 315 | $ 563 | |
Stated interest rate (as a percent) | 4.25% | 4.25% | |
4.150% Senior Notes due Nov 1, 2025 | |||
Current and long-term obligations | |||
Long-term obligations | $ 499,816 | $ 499,751 | |
Discount on debt issuance | $ 184 | $ 249 | |
Stated interest rate (as a percent) | 4.15% | 4.15% | |
3.875% Senior Notes due April 15. 2027 | |||
Current and long-term obligations | |||
Long-term obligations | $ 599,828 | $ 599,793 | |
Discount on debt issuance | $ 172 | $ 207 | |
Stated interest rate (as a percent) | 3.875% | 3.875% | |
4.625% Senior Notes Due Nov 1, 2027 | |||
Current and long-term obligations | |||
Long-term obligations | $ 549,576 | $ 549,505 | |
Discount on debt issuance | $ 424 | $ 495 | |
Stated interest rate (as a percent) | 4.625% | 4.625% | |
4.125% Senior Notes due May 1, 2028 | |||
Current and long-term obligations | |||
Long-term obligations | $ 499,750 | $ 499,713 | |
Discount on debt issuance | $ 250 | $ 287 | |
Stated interest rate (as a percent) | 4.125% | 4.125% | |
5.200% Senior Notes due July 5, 2028 | |||
Current and long-term obligations | |||
Long-term obligations | $ 499,870 | ||
Discount on debt issuance | $ 130 | $ 100 | $ 0 |
Amount borrowed | $ 500,000 | ||
Stated interest rate (as a percent) | 5.20% | 5.20% | |
3.500% Senior Notes due April 3, 2030 | |||
Current and long-term obligations | |||
Long-term obligations | $ 940,823 | 952,440 | |
Discount on debt issuance | $ 457 | $ 504 | |
Stated interest rate (as a percent) | 3.50% | 3.50% | |
5.000% Senior Notes due Nov 1, 2032 | |||
Current and long-term obligations | |||
Long-term obligations | $ 697,796 | $ 697,654 | |
Discount on debt issuance | $ 2,204 | $ 2,346 | |
Stated interest rate (as a percent) | 5% | 5% | |
5.450% Senior Notes due July 5, 2033 | |||
Current and long-term obligations | |||
Long-term obligations | $ 998,449 | ||
Discount on debt issuance | $ 1,551 | $ 1,600 | $ 0 |
Amount borrowed | $ 1,000,000 | ||
Stated interest rate (as a percent) | 5.45% | 5.45% | |
4.125% Senior Notes due April 3, 2050 | |||
Current and long-term obligations | |||
Long-term obligations | $ 495,305 | 495,234 | |
Discount on debt issuance | $ 4,695 | $ 4,766 | |
Stated interest rate (as a percent) | 4.125% | 4.125% | |
5.500% Senior Notes due Nov 1, 2052 | |||
Current and long-term obligations | |||
Long-term obligations | $ 299,711 | $ 299,708 | |
Discount on debt issuance | $ 289 | $ 292 | |
Stated interest rate (as a percent) | 5.50% | 5.50% | |
Senior Notes Due July 2028 And 2033 | |||
Current and long-term obligations | |||
Debt issue costs | $ 12,400 | ||
Unsecured commercial paper notes | |||
Current and long-term obligations | |||
Long-term obligations | $ 198,100 | $ 1,501,900 | |
Maximum maturity | 364 days | ||
Maximum aggregate borrowing amount | $ 2,000,000 | ||
Weighted average interest rate (as a percent) | 5.40% | ||
Unsecured commercial paper notes | Wholly-owned subsidiary | |||
Current and long-term obligations | |||
Long-term obligations | $ 197,700 | $ 230,800 | |
Letter Of Credit Outside Of Revolving Facility | |||
Current and long-term obligations | |||
Letters of credit outstanding | $ 43,200 |
Assets and liabilities measur_3
Assets and liabilities measured at fair value (Details) - USD ($) $ in Thousands | Nov. 03, 2023 | Feb. 03, 2023 |
Liabilities: | ||
Current portion of long-term obligations | $ 750,000 | |
Long-term obligations | 6,440,845 | $ 7,009,399 |
Reported amount | Current portion of long-term debt obligations | ||
Liabilities: | ||
Current portion of long-term obligations | 750,000 | |
Reported amount | Long-term obligations | ||
Liabilities: | ||
Long-term obligations | 6,440,845 | |
Reported amount | Accrued expenses and other current liabilities | ||
Liabilities: | ||
Deferred compensation | 10,164 | |
Reported amount | Noncurrent Other liabilities | ||
Liabilities: | ||
Deferred compensation | 35,951 | |
Fair value measurements on recurring basis | Balance at the end of the period | ||
Liabilities: | ||
Current and long-term obligations | 6,722,677 | |
Deferred compensation | 46,115 | |
Fair value measurements on recurring basis | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | ||
Liabilities: | ||
Current and long-term obligations | 6,318,958 | |
Deferred compensation | 46,115 | |
Fair value measurements on recurring basis | Significant Other Observable Inputs (Level 2) | ||
Liabilities: | ||
Current and long-term obligations | $ 403,719 |
Segment reporting (Details)
Segment reporting (Details) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Nov. 03, 2023 USD ($) segment store | Oct. 28, 2022 USD ($) segment | Nov. 03, 2023 USD ($) store segment | Oct. 28, 2022 USD ($) segment | |
Net sales data for classes of similar products | ||||
Net sales | $ 9,694,082 | $ 9,464,891 | $ 28,833,095 | $ 27,641,956 |
Number of reportable segments | ||||
Number of reportable operating segments | segment | 1 | 1 | 1 | 1 |
MEXICO | ||||
Number of reportable segments | ||||
Number of Retail Stores Operated | store | 2 | 2 | ||
Consumables | ||||
Net sales data for classes of similar products | ||||
Net sales | $ 7,940,527 | $ 7,664,806 | $ 23,445,031 | $ 22,101,146 |
Seasonal | ||||
Net sales data for classes of similar products | ||||
Net sales | 940,632 | 942,831 | 2,979,474 | 2,991,113 |
Home products | ||||
Net sales data for classes of similar products | ||||
Net sales | 534,471 | 574,425 | 1,582,305 | 1,674,013 |
Apparel | ||||
Net sales data for classes of similar products | ||||
Net sales | $ 278,452 | $ 282,829 | $ 826,285 | $ 875,684 |
Common stock transactions (Deta
Common stock transactions (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 1 Months Ended | 3 Months Ended | 9 Months Ended | |||||
Aug. 24, 2022 | Dec. 31, 2023 | Nov. 03, 2023 | Aug. 04, 2023 | May 05, 2023 | Oct. 28, 2022 | Nov. 03, 2023 | Oct. 28, 2022 | |
Common stock transactions | ||||||||
Aggregate purchase price | $ 546,455 | $ 1,641,851 | ||||||
Cash dividend paid (in dollars per share) | $ 0.59 | $ 0.59 | $ 0.59 | $ 0.55 | $ 1.77 | $ 1.65 | ||
Subsequent event | ||||||||
Common stock transactions | ||||||||
Cash dividend declared (in dollars per share) | $ 0.59 | |||||||
Common Stock | ||||||||
Common stock transactions | ||||||||
Shares acquired under share repurchase program | 2,256 | 7,142 | ||||||
Aggregate purchase price | $ 1,973 | $ 6,249 | ||||||
Common Stock | Pursuant to Authorized Repurchase Program | ||||||||
Common stock transactions | ||||||||
Common stock repurchase program, increase in the authorized amount | $ 2,000,000 | |||||||
Common stock repurchase authorization | $ 16,000,000 | |||||||
Shares acquired under share repurchase program | 0 | 7,100 | ||||||
Aggregate purchase price | $ 1,600,000 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Nov. 03, 2023 | Oct. 28, 2022 | Nov. 03, 2023 | Oct. 28, 2022 | |
Pay vs Performance Disclosure | ||||
Net Income (Loss) | $ 276,246 | $ 526,167 | $ 1,259,461 | $ 1,756,854 |
Insider Trading Arrangements
Insider Trading Arrangements | 9 Months Ended |
Nov. 03, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |